Close menu




October 15th, 2020 | 13:16 CEST

Bayer, Triumph Gold, BioNTech - decisive phase!

  • Investments
Photo credits: pixabay.com

Almost everyone knows the philosophies proclaimed by the great and wise stock market gurus. “Never try catch a falling knife" or "buy on the sound of cannons, sell on the sound of trumpets”. What is true? In the case of Bayer, after the Monsanto disaster, possibly higher than planned fines and a cracking profit warning, one might think that everything has already been priced in. However, it is still not known how and when the Monsanto disaster will end. The fact is, there are other, more appealing papers at the moment ...

time to read: 2 minutes | Author: Stefan Feulner
ISIN: CA8968121043 , DE000BAY0017 , US09075V1026

Table of contents:


    Trust from Switzerland

    Despite a stable market environment, Bayer continued to move south. Dropping below the EUR 45.00 mark marked a 5-year low. The Leverkusen-based Company was encouraged by the Swiss, of all countries. The major Swiss bank UBS left the rating for Bayer at "Buy" with a price target of EUR 85.00. Despite the announced dividend cut, UBS does not necessarily see Bayer as lacking money. The analyst cites as the reason that the pharmaceutical giant only issued a bond with a volume of EUR 6 billion in August.

    Besides, it would also be possible to generate cash by selling shares. Given the profit warning that was issued shortly before the issuing of the bond and the continuing uncertainty about possible fines, caution is still necessary at the current level.

    Before all-time high

    Everything else how bad things are going at the moment for the Mainz-based developer of a vaccine against the pandemic pathogen. The exploding COVID-19 infection figures are another reason why the Company is on everyone's lips.

    The vaccine candidate BNT162, developed in cooperation with Pfizer, is currently being tested in final clinical trials. About 37,000 participants in the study have already received vaccinations, 28,000 have received two doses. There are 120 sites worldwide involved in this clinical study.

    From a chartist's point of view, the upward trend, which has been in evidence since October 2019 and currently stands at EUR 55.00, is fully intact. If the positive news continues in the coming weeks, it is only a matter of time before the EUR 100.00 mark is reached and broken through.

    Opportunity after consolidation

    The stock of the Canadian gold explorer Triumph Gold also corrected sharply. In August 2020, the share price was at CAD 0.48, but now almost half of it is at CAD 0.25. The reasons for the fall to the south are, on the one hand, the weakening gold price and, of course, the still too weak sales due to the Company's high profile, this of course results in increased volatility, but also a great opportunity.

    Triumph Gold Corp. is a growth-oriented Canadian gold exploration and development company with a large land package in the mining-friendly Yukon. The Company's flagship project, Freegold Mountain, is located in the Dawson Range. It hosts three NI 43-101 compliant mineral deposits. It covers an extensive area of the Big Creek Fault Zone, a structure similar to epithermal gold and silver mineralization, and gold-rich porphyry copper mineralization.

    Successful Exploration Program

    As of September 18, 2020, Triumph Gold announced that it had completed the fully funded exploration program PR20-07. The program included minor trenching and reconnaissance sampling, as well as 2,068 meters of diamond drilling. The partially near-surface surveys are now in the evaluation and analysis phase. According to Jesse Halle, Vice President of Exploration, several of the reconnaissance samples collected indicate that gold mineralization is much more widespread than previously thought. As a result, the 2021 exploration program is to expand.

    Also noteworthy is the Canadian shareholder list, which includes known names. In addition to the Zijn Mining Fund, industry leader Newmont Mining is also a shareholder.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Carsten Mainitz on November 11th, 2026 | 05:33 CET

    Boom with a Few Hurdles? Almonty, Rheinmetall and Renk Put to the Test! Is Now the Time to Buy?

    • Tungsten
    • Tungsten producer
    • Commodities
    • Critical raw materials
    • Military
    • Defence industry
    • Geopolitics
    • Investments

    Commodities, defence, returns. This formula for success has developed cracks. Following the recent sharp share price pullbacks, the crucial question is whether these are now buying opportunities or warning signals? With tungsten, Almonty is focusing on a strategic raw material with growing demand and considerable geopolitical significance. With the ramp-up of the South Korean Sangdong mine, Almonty is on the verge of a strong growth spurt. High prices, long-term offtake agreements and a further expansion phase also strengthen the sales outlook. Business at specialist Renk is running at full tilt. Following another forecast cut, Rheinmetall must offer investors a more reliable outlook. Where are the most attractive opportunities now?

    Read

    Commented by Carsten Mainitz on November 5th, 2026 | 05:27 CET

    Desert Gold, Heidelberger Druckmaschinen and Evonik: Where is the stock market underestimating the potential?

    • Gold
    • Precious metals
    • Exploration
    • Gold production
    • Africa
    • Mali
    • Transformation
    • Group restructuring
    • Profit warning
    • Investments
    • Stock Picking
    • Takeover offer

    Prepared and published on behalf of Desert Gold Ventures.

    The reporting season could hardly be more contrasting. While Evonik is impressing with higher earnings, Heidelberger Druck is shocking the market with a profit warning. Meanwhile, Desert Gold is on the verge of its first precious metal production. Analysts consider all three stocks to be undervalued. Research firm GBC even sees enormous upside potential of more than 600% for Desert Gold. Are these stocks now poised for a fundamental revaluation, or are investors knowingly walking into a value trap? We take a closer look!

    Read

    Commented by Carsten Mainitz on November 3rd, 2026 | 05:33 CET

    Hit or Miss? Diesel, dynaCERT, Deutz and Daimler Truck – Assessing the prospects in a changing commercial vehicle industry

    • Bridging technology
    • Diesel
    • Hydrogen
    • Emissions
    • Innovations
    • Lorries
    • Investments

    Retrofit, convert or replace? When will the transition to new powertrains gain momentum? dynaCERT aims to make existing diesel engines more efficient using its hydrogen technology. Deutz is expanding its engine business to include energy and defence technology. Daimler Truck combines its established commercial vehicle business with the development of new powertrains. Sooner or later, the shift towards lower-emission commercial vehicles will inevitably come down to hard numbers. When and how do these investments pay off? Which company has the most convincing answers?

    Read